Related Experiment Video
Updated: Apr 21, 2026

Microsurgical Clip Obliteration of Middle Cerebral Aneurysm Using Intraoperative Flow Assessment
Published on: September 25, 2009
Flow diverter treatment for MCA M1 aneurysms: clinical outcomes and predictors of occlusion
Zeran Yu1,2,3,4, Jiabin Su1,2, Xinjie Gao1,2
1Department of Neurosurgery, Huashan Hospital of Fudan University, Shanghai, China.
Background:
The role of flow diverters (FDs) in middle cerebral artery (MCA) M1 aneurysms is not well established. We assessed their safety, efficacy, and predictors of incomplete occlusion.
Methods:
Consecutive MCA M1 aneurysms treated with FDs (January 2022-May 2024) were retrospectively reviewed. Clinical, imaging, and procedural variables were analyzed for associations with ischemic complications and angiographic outcomes.
Results:
Fifty-eight patients (mean age 57.5 years; 46.6% female) underwent treatment with Pipeline (56.9%), Tubridge (20.7%), Surpass Evolve (12.1%), or Lattice (10.3%) devices. Postprocedural cerebral ischemia occurred in 25.9% (15/58), significantly more often in ruptured versus unruptured aneurysms (26.7% vs. 2.3%, p = 0.013). Rupture independently predicted ischemia (OR 15.273, 95% CI 1.547-150.765; p = 0.020). At a median follow-up of 13 months, complete occlusion was achieved in 77.4% (41/53). Aneurysm wall enhancement on MRI independently predicted incomplete occlusion (OR 6.566, 95% CI 1.395-30.903; p = 0.017).
Conclusion:
FDs may be an option for carefully selected MCA M1 aneurysms. Ruptured aneurysms are associated with a markedly higher risk of postoperative ischemic complications, and aneurysm wall enhancement on preoperative MRI independently predicts incomplete aneurysm occlusion after FDs treatment.
Insights
Flow diverters (FDs) offer a treatment option for middle cerebral artery (MCA) M1 aneurysms. Ruptured aneurysms increase ischemic risk, while MRI-detected wall enhancement predicts incomplete occlusion.
Area of Science:
- Neuroendovascular therapy
- Cerebrovascular disease management
- Medical device innovation
Background:
- The efficacy and safety of flow diverters (FDs) for middle cerebral artery (MCA) M1 aneurysms remain under investigation.
- Assessing predictors of incomplete occlusion is crucial for optimizing treatment outcomes.
Purpose of the Study:
- To evaluate the safety and efficacy of FDs in treating MCA M1 aneurysms.
- To identify factors associated with incomplete aneurysm occlusion and postoperative ischemic complications.
Main Methods:
- Retrospective review of consecutive MCA M1 aneurysms treated with FDs between January 2022 and May 2024.
- Analysis of clinical, imaging, and procedural variables to determine associations with ischemic events and angiographic results.
Main Results:
- Postprocedural cerebral ischemia occurred in 25.9% of patients, with a significantly higher incidence in ruptured aneurysms (26.7% vs. 2.3%).
- Rupture was an independent predictor of ischemia (OR 15.273).
- Complete occlusion was achieved in 77.4% of aneurysms at a median 13-month follow-up, with aneurysm wall enhancement on MRI predicting incomplete occlusion (OR 6.566).
Conclusions:
- Flow diverters represent a potential treatment for select MCA M1 aneurysms.
- Ruptured aneurysms carry a substantially higher risk of postoperative ischemic complications.
- Preoperative MRI evidence of aneurysm wall enhancement is an independent predictor of incomplete occlusion following FD treatment.
Related Concept Videos
Aneurysm III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies

